Enucleation for retinoblastoma: the experience of a single center in Jordan
- 28 April 2010
- journal article
- research article
- Published by Springer Nature in International Ophthalmology
- Vol. 30 (4) , 407-414
Abstract
Despite multiple advances in the management of retinoblastoma, enucleation remains an essential therapeutic modality. We studied patients who underwent enucleation at the King Hussein Cancer Center in Jordan. We retrospectively reviewed medical records of children with retinoblastoma who were treated at our center from June 2002 to February 2008. Twenty-eight eyes from 27 patients were enucleated. Median age at diagnosis was 1.1 years (range, 0.3–6.3 years). Twenty-six eyes (93%) had advanced disease (RE groups IV and V). Seventeen patients (61%) had unilateral retinoblastoma, and 11 (39%) had bilateral retinoblastoma. The median time from diagnosis to enucleation was 0.45 months (range, 0–45 months; mean, 4.4 months) and was longer for patients with bilateral retinoblastoma (median, 2.2 vs. 0.2 months; P = 0.034). Twenty enucleated eyes (71%) did not show high-risk pathologic features. Seventeen eyes with advanced intraocular disease were enucleated at the time of presentation, whereas chemoreduction was attempted for the other 19 eyes with advanced intraocular disease. Enucleation was then recommended for nine (47%) of those eyes. Enucleation at the time of diagnosis was feasible for most patients with advanced disease. Attempted salvage of eyes with advanced disease is justified, particularly in patients with bilateral disease. We were able to salvage almost half of these eyes. We hope our study provides new insights for counseling patients.Keywords
This publication has 18 references indexed in Scilit:
- The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and deathBritish Journal of Ophthalmology, 2009
- Clinical Nurse Coordinators: A New Generation of Highly Specialized Oncology Nursing in JordanJournal of Pediatric Hematology/Oncology, 2009
- Team management, twinning, and telemedicine in retinoblastoma: A 3‐tier approach implemented in the first eye salvage program in JordanPediatric Blood & Cancer, 2008
- World disparities in risk definition and management of retinoblastoma: A report from the International Retinoblastoma Staging Working GroupPediatric Blood & Cancer, 2008
- Retinoblastoma: Review of Current ManagementThe Oncologist, 2007
- Impact of an education program on late diagnosis of retinoblastoma in HondurasPediatric Blood & Cancer, 2006
- A proposal for an international retinoblastoma staging systemPediatric Blood & Cancer, 2005
- Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?British Journal of Ophthalmology, 2004
- Unilateral retinoblastoma: new intraocular tumours after treatment.British Journal of Ophthalmology, 1994
- Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors.British Journal of Ophthalmology, 1993